Last A$0.36 AUD
Change Today -0.005 / -1.37%
Volume 18.5K
ACL On Other Exchanges
Symbol
Exchange
OTC US
OTC US
Frankfurt
As of 8:12 PM 05/23/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Wim D. F. Meutermans Ph.D.

Vice President of Drug Discovery, Alchemia Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

--A$268,305
As of Fiscal Year 2012

Background*

Dr. Wim D. F. Meutermans, Ph.D. has been Vice President of Discovery at Audeo Oncology, Inc. since June 2012. Dr. Meutermans serves as Vice President of Drug Discovery at Alchemia Limited. He served as Vice President of Drug Development at Alchemia Limited. He served as Director of Research of Alchemia Limited from 2006 to 2007 and served its Director of Chemistry from 2002 to 2006. He served as Head of Combinatorial Chemistry/Senior Combinatorial Chemist at Alchemia ...

Read Full Background

Corporate Headquarters*

3 Hi –Tech Court Brisbane Technology Park
Brisbane, Queensland 4113

Australia

Phone: 61 7 3340 0200
Fax: 61 7 3340 0222

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1988
Katholieke Universiteit Leuven

Other Affiliations*

Annual Compensation*

SalaryA$201,196
BonusA$4,661
Total Annual CompensationA$205,857

Stock Options*

Restricted Stock AwardsA$18,646
All Other CompensationA$31,599
Exercisable Options250,000
Unexercisable Options70,000
Total Number of Options320,000

Total Compensation*

Total Annual Cash CompensationA$237,456
Total Short Term CompensationA$205,857
Other Long Term CompensationA$50,245
Total Calculated CompensationA$268,305
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACL:AU A$0.36 AUD -0.005

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Geoffrey Paul Kempler B.Sc, Grad.Dip.App.Soc.PsychCo-Founder, Executive Chairman and Chief Executive Officer
Prana Biotechnology Limited
A$388.2K
Deborah Rathjen B.Sc. (Hons.), Ph.D., M.A.I.C.D.Chief Executive Officer, Managing Director and Director
Bionomics Ltd.
A$398.6K
Matthew Lehman Chief Executive Officer, Managing Director and Director
Prima Biomed Ltd.
A$248.3K
Larry Glass BA (Biology)Chief Executive Officer, Managing Director, President US Operations and Director
Neuren Pharmaceuticals Limited
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALCHEMIA LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.